Live Quote · NASDAQEDITHealthcare· Biotechnology

Editas Medicine, Inc.

$1.64▼ 4.09%($-0.07)
MKT CAP $253.12MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
69/100
▌ Solid
73
Valuation
40
Profitability
100
Growth
100
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EDIT research report →

Analyst Price Target
$5.50+235.4% vs. today

Range $5 – $6

Analyst RatingBuy
16 Buy8 Hold2 Sell

Price Chart

-33.60% · this period
$3.75$2.69$1.64Nov 20May 26Nov 20
52-Week Range0% of range
Low
$1.63
Current
$1.64
High
$3.94